CELH
Celsius Holdings, Inc.
CELH has the edge over PFGC overall, supported by stronger valuation and stronger fundamentals.
PFGC
Performance Food Group Company
PFGC has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
PFGC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Stable |
PFGC's profitability is currently healthy, and its revenue, cash flow and balance sheet are stable.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over PFGC in the historical PE scenario, which offers more potential upside but is not a forecast.
PFGC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $110 | — |
| Cheap | 26x | $65.62 | -40% |
| Fair | 36x | $89.18 | -19% |
| Current | 44x | $110 | — |
| Expensive | 71x | $177 | +61% |
Historical ranges are pointers, not guarantees.
PFGC's PE is in its fair range at 44x. If earnings grow as analysts expect, today's price would be 19x next year's earnings, in its cheap range.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over PFGC on the outlook, with more favorable profitability expectations.
PFGC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for PFGC, with profitability holding steady.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
PFGC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.88 | +134% |
| Q3 2026 | $2.51 | +20% |
| Q2 2026 | $2.29 | +5% |
| Q1 2026 | $2.11 | -12% |
| Q4 2025 | $2.21 | -11% |
| Q3 2025 | $2.09 | -23% |
| Q2 2025 | $2.18 | -22% |
| Q1 2025 | $2.40 | -10% |
| Q4 2024 | $2.48 | -9.2% |
PFGC has the edge over CELH on earnings, with stronger typical year-over-year growth.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over PFGC on profitability, with a higher operating margin.
PFGC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18B | +5.5% |
| Q2 2026 | $18B | +6.4% |
| Q1 2026 | $16.3B | +6.4% |
| Q4 2025 | $16.4B | +5.2% |
| Q3 2025 | $17.1B | +11% |
| Q2 2025 | $16.9B | +12% |
| Q1 2025 | $15.3B | +10% |
| Q4 2024 | $15.6B | +9.4% |
PFGC's revenue has grown year over year every quarter since late 2020: $18B last quarter, up 5.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +0.2 points |
| Q2 2026 | 1.8% | +0.2 points |
| Q1 2026 | 0.9% | -0.2 points |
| Q4 2025 | 1.2% | +0.1 points |
| Q3 2025 | 1.3% | -0.1 points |
| Q2 2025 | 1.6% | -0.3 points |
| Q1 2025 | 1.1% | 0 points |
| Q4 2024 | 1% | -0.2 points |
PFGC's operating margin was 1.5% last quarter, about level with the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
PFGC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$143.2M | +$80.9M |
| Q2 2026 | $223.6M | +6.6% |
| Q1 2026 | $542.3M | +70% |
| Q4 2025 | $487.8M | +124% |
| Q3 2025 | -$224.1M | -$181.1M |
| Q2 2025 | $209.7M | +281% |
| Q1 2025 | $319.3M | +4.6% |
| Q4 2024 | $218.1M | -42% |
PFGC has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over PFGC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
PFGC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +500K shares |
| 1 year | +0.4% | +600K shares |
| 3 years | +0.6% | +900K shares |
| 5 years | +12% | +16.3M shares |
| Available history | +48% | +51.1M shares |
PFGC has 158M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $600,000 |
| Q1 2026 | $900,000 |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $14M |
| Q1 2025 | $10M |
| Q4 2024 | $4.4M |
| Q3 2024 | $29.2M |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over PFGC on leverage, with a lower net debt burden relative to earnings.
PFGC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.9x | Moderate |
| Q2 2026 | 2.9x | Moderate |
| Q1 2026 | 3.1x | Elevated |
| Q4 2025 | 3.2x | Elevated |
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 3.5x | Elevated |
| Q1 2025 | 3.6x | Elevated |
| Q4 2024 | 4.0x | Elevated |
PFGC's net debt is about 2.9 years of its operating earnings (EBITDA), down from 3.5 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
PFGC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.8 | Neutral |
| Stochastic | 60.3 | Neutral |
PFGC's weekly RSI is 62 (neutral) and its Stochastic is 60 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH has the edge over PFGC on valuation relative to its sector.
PFGC PE vs Consumer Defensive Sector
| Metric | PFGC | Sector median | Relative |
|---|---|---|---|
| PE | 44x | 19x | 125% above |
| PE % | 62 | 18 | 44 pts above |
PFGC is trading at 44x earnings, a 125% premium to the Consumer Defensive sector's median of 19x.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
PFGC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $98.7 | 11% above |
| 20 week MA | $103.3 | 6.5% above |
| 50 week MA | $97.4 | 13% above |
| 100 week MA | $93.9 | 17% above |
| 200 week MA | $80.5 | 37% above |
PFGC has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
PFGC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.2 | $48.0 | -6.2% |
| 2021 | $48.0 | $45.2 | -5.9% |
| 2022 | $45.2 | $59.9 | +33% |
| 2023 | $59.9 | $69.2 | +15% |
| 2024 | $69.2 | $85.1 | +23% |
| 2025 | $85.1 | $91.8 | +7.9% |
| 2026 YTD | $91.8 | $110.0 | +20% |
PFGC has the edge over CELH on returns for 2026, with the stronger performance.